Xponance Inc. Sells 7,550 Shares of UnitedHealth Group Incorporated (NYSE:UNH)
Xponance Inc. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 156,105 shares of the healthcare conglomerate’s stock after selling 7,550 shares during the period. UnitedHealth Group makes up approximately 1.2% of Xponance Inc.’s portfolio, making the stock its 9th biggest holding. Xponance Inc.’s holdings in UnitedHealth Group were worth $48,669,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. JustInvest LLC grew its stake in UnitedHealth Group by 18.9% in the 3rd quarter. JustInvest LLC now owns 10,235 shares of the healthcare conglomerate’s stock valued at $3,191,000 after acquiring an additional 1,626 shares during the last quarter. Meritage Portfolio Management grew its stake in UnitedHealth Group by 0.9% in the 3rd quarter. Meritage Portfolio Management now owns 12,596 shares of the healthcare conglomerate’s stock valued at $3,927,000 after acquiring an additional 113 shares during the last quarter. Sheets Smith Wealth Management boosted its stake in shares of UnitedHealth Group by 20.4% during the 3rd quarter. Sheets Smith Wealth Management now owns 7,822 shares of the healthcare conglomerate’s stock worth $2,439,000 after purchasing an additional 1,328 shares during the last quarter. Hyman Charles D boosted its stake in shares of UnitedHealth Group by 16.3% during the 3rd quarter. Hyman Charles D now owns 6,914 shares of the healthcare conglomerate’s stock worth $2,156,000 after purchasing an additional 971 shares during the last quarter. Finally, Moser Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 3.6% during the 3rd quarter. Moser Wealth Advisors LLC now owns 5,045 shares of the healthcare conglomerate’s stock worth $1,573,000 after purchasing an additional 175 shares during the last quarter. 86.39% of the stock is currently owned by institutional investors.
Several research firms have issued reports on UNH. Barclays raised their price target on shares of UnitedHealth Group from $322.00 to $365.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 13th. Morgan Stanley reaffirmed a “buy” rating and set a $371.00 price target on shares of UnitedHealth Group in a research note on Thursday, July 16th. ValuEngine raised shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a research note on Thursday, October 1st. Credit Suisse Group set a $335.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Wednesday, October 14th. Finally, SVB Leerink raised their target price on shares of UnitedHealth Group from $370.00 to $373.00 and gave the stock an “outperform” rating in a research report on Thursday, October 15th. Five investment analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $346.68.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share for the quarter, beating analysts’ consensus estimates of $2.98 by $0.53. The company had revenue of $65.12 billion during the quarter, compared to analysts’ expectations of $63.97 billion. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The firm’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the prior year, the company posted $3.88 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 16.78 EPS for the current year.
In other UnitedHealth Group news, EVP Marianne D. Short sold 12,000 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $321.34, for a total value of $3,856,080.00. Following the completion of the transaction, the executive vice president now directly owns 140,885 shares of the company’s stock, valued at approximately $45,271,985.90. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Marianne D. Short sold 10,336 shares of the company’s stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $312.34, for a total transaction of $3,228,346.24. Over the last three months, insiders sold 135,915 shares of company stock valued at $44,372,099. 0.80% of the stock is currently owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Further Reading: What is a CD ladder?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.